
Terry Riss
Global Strategic Manager, Cell Health
Promega Corporation
Dr. Riss received a PhD in Cell Biology from the University of Illinois in 1978 in the field of mammary gland biology. He did postdoctoral work at the University of Texas Medical School in Houston purifying growth factors involved with breast cancer and developing serum-free media formulations to implement bioassays. Dr. Riss moved to the Biotechnology division of Schering Plough in 1988 to develop interleukin/cytokine bioassays to support investigational new drug filings. Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and has held several R&D and Project Management positions. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and also lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Global Strategic Marketing Manager, Cell Health involved in outreach educational training activities. Dr. Riss has participated in several NIH study sections reviewing HTS grants and is co-editor of the cell culture assays section of the Assay Guidance Manual hosted by NIH.
Presentation(s):
-
3D Cell-Based Assays for Drug De-Risking
Saturday, February 3
8:00 AM – 3:15 PM -
Assay Guidance Workshop for High Throughput Screening and Lead Discovery
Saturday, February 3
8:00 AM – 5:00 PM -
Establishing Cell-Based Assays for Screening
Sunday, February 4
8:00 AM – 3:15 PM -
Real-Time Cell Health Assays Deliver Better Data with Less Effort
Monday, February 5
12:30 PM – 1:15 PM